Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
16.25
-0.23 (-1.40%)
Streaming Delayed Price
Updated: 12:09 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Neogenomics Inc
< Previous
1
2
3
4
5
6
Next >
EQUITY ALERT: Rosen Law Firm Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEO
December 07, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
December 07, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
December 07, 2022
From
Kirby McInerney LLP
Via
Business Wire
NeoGenomics Announces Chief Financial Officer Transition
December 05, 2022
Via
ACCESSWIRE
NeoGenomics Reports Third Quarter 2022 Results
November 08, 2022
Via
ACCESSWIRE
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
September 07, 2022
Via
ACCESSWIRE
NeoGenomics Reports Revenue of $125 Million in the Second Quarter
August 09, 2022
Via
ACCESSWIRE
INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEO
December 07, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
December 07, 2022
From
The Schall Law Firm
Via
Business Wire
CORRECTING and REPLACING NEOGENOMICS INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit on Behalf of NEO Investors
December 06, 2022
From
Gibbs Law Group
Via
Business Wire
NeoGenomics Announces Chief Executive Officer Appointment
July 21, 2022
Via
ACCESSWIRE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm
December 06, 2022
From
The Schall Law Firm
Via
Business Wire
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
Via
ACCESSWIRE
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
November 30, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END
Via
FinancialNewsMedia
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
November 21, 2022
Via
ACCESSWIRE
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)
November 18, 2022
Via
ACCESSWIRE
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
November 07, 2022
Via
ACCESSWIRE
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
October 28, 2022
Via
ACCESSWIRE
NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022
October 13, 2022
Via
ACCESSWIRE
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2022
Via
ACCESSWIRE
NeoGenomics Announces Chief Executive Officer Appointment
July 21, 2022
Chris Smith named CEO effective August 15, 2022; Interim CEO Lynn Tetrault to resume role of independent Chair of the Board
From
NeoGenomics, Inc.
Via
AccessWire
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
July 15, 2022
FT. MYERS, FL / ACCESSWIRE / July 15, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...
From
NeoGenomics, Inc.
Via
AccessWire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
June 27, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
June 24, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Its Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
June 24, 2022
From
Law Offices of Frank R. Cruz
Via
Business Wire
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
June 21, 2022
FT. MYERS, FL / ACCESSWIRE / June 21, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today confirms...
From
NeoGenomics, Inc.
Via
AccessWire
Lost Money in NeoGenomics, Inc.?
June 03, 2022
From
Gibbs Law Group
Via
Business Wire
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
June 03, 2022
FT. MYERS, FL / ACCESSWIRE / June 3, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...
From
NeoGenomics, Inc.
Via
AccessWire
NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
June 03, 2022
CAP Certification Expands Global Strategic Capabilities Supporting Biopharma R&D
From
NeoGenomics, Inc.
Via
AccessWire
NASDAQ:NEO Investor Alert: Investigation over Possible Wrongdoing at NeoGenomics, Inc.
June 02, 2022
San Diego, CA -- (SBWIRE) -- 06/02/2022 -- Certain directors of NeoGenomics, Inc. are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.